Seonix Bio launched SightScore, a polygenic risk score testing service for primary open-angle glaucoma, in the United States, according to a press release.

Participants were also administered the Ocular Surface Disease Index ... designed to specifically target the Meibomian gland, while the majority of previous studies have primarily assessed the ...

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 24,705.34 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...

The FDA granted 510(k) clearance for the VIA360 surgical system, which is designed to deliver viscoelastic fluid during ophthalmic surgeries, according to a press release from New World Medical ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The natural history of ...